Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Electromed Gets FDA Market Clearance For SmartVest SQL - Quick Facts

Electromed Inc. (ELMD: Quote), a global medical device company, said it has received notification from the U.S. Food and Drug Administration that its next generation SmartVest Airway Clearance System, the model SQL has been cleared to market.

"SQL solidifies Electromed's innovation leadership by offering a device that is smaller, quieter, and lighter than our previous versions," said Kathleen Skarvan, Chief Executive. He added, "We designed the SQL to stand apart from the competition with features that our patients and clinicians were asking for. They talked, and we listened."

The model SQL is an electrically powered precursor device designed to deliver high frequency chest wall oscillation to promote airway clearance, improve bronchial drainage and enhance mucus transport under the order of a physician's prescription.

The model SQL is expected to be available to the U.S. market within the next 60 days.

Click here to receive FREE breaking news email alerts for Electromed Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Incumbent Colorado Sen. Mark Udall, D-Col., trails his Republican challenger in the latest Quinnipiac University poll, with more than a third of likely voters describing their U.S. Senate vote as a vote against President Barack Obama. A bipartisan coalition in the House voted Wednesday evening to approve a measure providing the U.S. military with the authority to train and arm moderate Syrian rebels against the terrorist group known as the Islamic State. The House voted 273 to 156 in favor of the measure, which was attached to a larger spending bill to temporarily fund the government. After moving mostly higher early in the session, stocks have continued to perform well over the course of the trading day on Thursday. The gains on the day have lifted both the Dow and the S&P 500 to new record intraday highs.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.